CABA Company Profile and Key Details
Cabaletta Bio, Inc.
CABA Stock Price Chart
Stock Price Today
Cabaletta Bio, Inc. (CABA) stock declined over -3.88%, trading at $2.50 on NASDAQ, down from the previous close of $2.60. The stock opened at $2.62, fluctuating between $2.49 and $2.70 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Company Information
| Employees | 136 |
| Beta | 2.42 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Cabaletta Bio, Inc. (NASDAQ: CABA) stock price is $2.50 in the last trading session. During the trading session, CABA stock reached the peak price of $2.70 while $2.49 was the lowest point it dropped to. The percentage change in CABA stock occurred in the recent session was -3.88% while the dollar amount for the price change in CABA stock was -$0.10.
The NASDAQ listed CABA is part of Biotechnology industry that operates in the broader Healthcare sector. Cabaletta Bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Michael Gerard J.D.
Gen. Counsel & Sec.
Ms. Martha O'Connor
Chief HR Officer
Ms. Heather Harte-Hall M.Sc.
Chief Compliance Officer
Dr. Michael C. Milone M.D., Ph.D.
Co-Founder & Co-Chair of Scientific Advisory Board
Dr. David J. Chang FACR, M.D., M.P.H.
Chief Medical Officer
Mr. Anup Marda M.B.A.
Chief Financial Officer
Dr. Samik Basu M.D.
Chief Scientific Officer
Dr. Aimee Payne M.D., Ph.D.
Co-Founder & Co-Chair of Scientific Advisory Board
Dr. Gwendolyn K. Binder Ph.D.
Pres of Science & Technology
Dr. Steven A. Nichtberger M.D.
Co-Founder, Chairman, Chief Executive Officer & Pres
CABA's closing price is 47.73% higher than its 52-week low of $1.76 where as its distance from 52-week high of $26.35 is -90.13%.
Number of CABA employees currently stands at 136.
Official Website of CABA is: https://www.cabalettabio.com
CABA could be contacted at phone 267 759 3100 and can also be accessed through its website. CABA operates from 2929 Arch Street, Philadelphia, PA 19104, United States.
CABA stock volume for the day was 617.49K shares. The average number of CABA shares traded daily for last 3 months was 2.59M.
The market value of CABA currently stands at $122.14M with its latest stock price at $2.50 and 48.88M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com